Skip to main content
Aislinn Antrim on Muck Rack

Aislinn Antrim

Verified
As seen in: Pharmacy Times, WRAL-TV (Raleigh, NC), NewsBreak, Winston-Salem Journal, The Daily Tar Heel, American Journal of Managed Care, Indian Country Today, Contemporary OB/GYN, EducationNC, Patient Care, Center for Biosimilars
Journalist at Pharmacy Times | UNC '19 | Interests in politics, long-form storytelling, and cats
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Aislinn

Contact Aislinn, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Inpatient Biosimilar Use Grows, Offering Cost-Saving Opportunities for Health Systems

|
By Aislinn Antrim Verified
| Center for Biosimilars
Biosimilar adoption in inpatient settings has increased, offering financial benefits without compromising patient care, especially in oncology and supportive care. From 2019 to 2024, biosimilars accounted for 24.4% of inpatient encounters, with significant growth in supportive care and oncology. The study found a mean 35% reduction in wholesale acquisition costs for biosimilars compared to reference products, highlighting cost-saving potential.
Open in Who Shared Issue with article?

New Treatments Are Changing the Future of Alzheimer Disease

|
By Aislinn Antrim Verified
| NewsBreak
By signing up for our newsletter, you agree to our Terms of Use and Privacy Policy It’s essential to note our commitment to transparency: Our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies.
Open in Who Shared View Duplicates (62) Issue with article?

FDA Advisory Panel Rejects MDMA-Assisted Therapy for PTSD

|
By Aislinn Antrim Verified
| NewsBreak
Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments.
Open in Who Shared View Duplicates (191) Issue with article?
See all 39 licensed articles (1,156 Total)